BIOLOGICAL PREPARATIONS IMMUNOTHERAPHY

Brand Owner Address Description
I.D.M., THE IMMUNOGENICS COMPANY I.D.M. IMMUNO-DESIGNED MOLECULES 172, rue de Charonne F-75011 PARIS France Biological preparations for immunotheraphy, cellular and gene therapy, for medical, pharmaceutical or veterinary use;IDM THE IMMUNOGENICS COMPANY;Chemical reagents for research and medical use in immunotherapy; cellular preparations for medical, pharmaceutical or veterinary use, namely, immune or blood cells manipulated ex vivo and intended to recognize target cells for laboratory, medical and pharmaceutical use, for laboratory tests, for validation tests and for quality control tests;Medical diagnostic kits and cases consisting primarily of cells processors for the preparation of cells for medical, pharmaceutical or veterinary use;THE IMMUNOGENICS COMPANY;Fundamental and applied scientific research in the biomedical, agribusiness, agricultural, and therapy fields;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.